CRISPR/dCas9 DNA methylation editing is heritable during human hematopoiesis and can impair differentiation in vivo (2023)
Attributed to:
Elucidating the molecular and epigenetic basis of cancer initiation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Parent Publication: PNAS